Presentation is loading. Please wait.

Presentation is loading. Please wait.

Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective  Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Majid.

Published by萱 祖 Modified over 5 years ago

Similar presentations

Presentation on theme: "Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective  Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Majid."— Presentation transcript:

1 Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective 
Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Majid Harmouche, MD, PhD, Erwan Flécher, MD, PhD, Hervé Corbineau, MD, Thierry Langanay, MD, Bernard Lelong, MD, Jean-Philippe Verhoye, MD, PhD, Alain Leguerrier, MD  The Annals of Thoracic Surgery  Volume 101, Issue 3, Pages (March 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Number of tricuspid valve replacements with either a mechanical prosthesis (blue columns) or a bioprosthesis (purple columns) and number of tricuspid valve repairs (green columns) performed at our hospital by decade. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Study outline. (TVR = tricuspid valve replacement.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier survival curves according to type of tricuspid valve replacement prosthesis, biological (red continuous lines) or mechanical (blue dotted lines). (A) Survival free from tricuspid valve-related death. (B) Survival free from Structural valve deterioration of tricuspid prosthesis. (C) Survival free from thromboembolic events related to tricuspid valve. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Kaplan-Meier survival curves stratified according to the type of tricuspid valve replacement prosthesis, biological (red continuous lines) or mechanical (blue dotted lines). (A) Survival free from reoperation on a tricuspid prosthesis. (B) Survival free from reoperation for Structural valve deterioration of a tricuspid prosthesis. (C) Survival free from the composite endpoint. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Appraisal of Long-Term Outcomes of Tricuspid Valve Replacement in the Current Perspective  Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Majid."

Similar presentations

Twenty-Five Year Experience With the St

Twenty-Five Year Experience With the St
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients  Danielle K. Farrington, MD, Patrick D. Kilgo,
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger  Thierry Bourguignon, MD, Rym El Khoury, MD, Pascal.

Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger  Thierry Bourguignon, MD, Rym El Khoury, MD, Pascal.
Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,
Unusual Gastrointestinal Bleeding After Sutureless Aortic Valve Replacement: A Word of Caution  Jules Iquille, MD, Joseph Nader, MD, Eric Colpart, MD,

Unusual Gastrointestinal Bleeding After Sutureless Aortic Valve Replacement: A Word of Caution  Jules Iquille, MD, Joseph Nader, MD, Eric Colpart, MD,
Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective  Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure

Outcomes of Reintervention on the Autograft After Ross Procedure
Aortic Valve Replacement in the Elderly: The Real Life

Aortic Valve Replacement in the Elderly: The Real Life
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement  Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Bernard Lelong,

Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement  Amedeo Anselmi, MD, PhD, Vito Giovanni Ruggieri, MD, PhD, Bernard Lelong,
A 10-Year Experience With the Carbomedics Cardiac Prosthesis

A 10-Year Experience With the Carbomedics Cardiac Prosthesis
Long-Term Outcome of Patients With Complete Atrioventricular Septal Defect Combined With the Tetralogy of Fallot: Staged Repair Is Not Inferior to Primary Repair 

Long-Term Outcome of Patients With Complete Atrioventricular Septal Defect Combined With the Tetralogy of Fallot: Staged Repair Is Not Inferior to Primary Repair 
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J
Operative Results and Outcomes in Children With Shone's Anomaly

Operative Results and Outcomes in Children With Shone's Anomaly
Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery?  Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery?  Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Similar presentations

Ads by Google